A multinational research team led by Columbia University and the La Jolla Institute for Immunology has identified a novel viral target that could help combat the global resurgence of measles.
A new study shows that an ancient mechanism of regulating a cell’s protein repertoire allows malaria parasites to hide from fast-acting artemisinin drugs and survive.
Jessica Justman, MD, an infectious disease specialist and epidemiologist at Columbia, says vaccinated people still need to take some precautions for now.
A virtual town hall hosted by CUIMC and NewYork-Presbyterian Hospital brought together community health workers and local leaders to discuss questions and concerns regarding the COVID-19 vaccines.
New Columbia study suggests current vaccines and monoclonal antibody therapies provide less neutralizing activity against the U.K. and South Africa variants of SARS-CoV-2.
A systematic screening program designed for athletes testing positive for COVID-19 has detected a low incidence of inflammatory heart disease, so far returning professional athletes safely to sport.
A 15-minute COVID-19 test that can be used at home to identify infectious people is under development in David Ho’s laboratory and has received support from the NYC Economic Development Corporation.
The first CUIMC Grand Rounds, launched by the four deans of Columbia University Irving Medical Center schools, was presented by David Ho, MD, on new variants of the coronavirus.
People who took statins to lower cholesterol were about 50% less likely to die if hospitalized for COVID-19, a retrospective study by Columbia University and NewYork-Presbyterian physicians has found.
Spread of a new SARS-CoV-2 variant in the New York City region that shares worrisome similarities with other recent variants has been identified by scientists at Columbia University.